Titre :
  • Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule.
Auteur : Awada, Ahmad ; Punt, Cornelis ; Piccart-Gebhart, Martine ; Van Tellingen, Olaf ; Van Manen, Lori ; Kerger, Joseph ; Groot, Yvonne ; Wanders, Jantien ; Verweij, Jaap ; Wagener, Th
Informations sur la publication : British Journal of Cancer, 79, 9-10, (page 1454-1461)
Statut de publication : Publié, 1999-03
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged
Antineoplastic Agents -- administration & dosage
Antineoplastic Agents -- adverse effects
Antineoplastic Agents -- pharmacokinetics
Benzofurans -- administration & dosage
Benzofurans -- adverse effects
Benzofurans -- pharmacokinetics
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Indoles -- administration & dosage
Indoles -- adverse effects
Indoles -- pharmacokinetics
Infusions, Intravenous
Male
Middle Aged
Neoplasms -- drug therapy
Neoplasms -- metabolism
Neoplasms -- pathology
Neutropenia -- chemically induced
Prodrugs -- administration & dosage
Prodrugs -- adverse effects
Thrombocytopenia -- chemically induced
Note : Clinical Trial
Clinical Trial, Phase I
Journal Article
Langue :
  • Anglais
Identificateurs : urn:issn:0007-0920 
info:doi/10.1038/sj.bjc.6690232
info:pmid/10188890
info:pmcid/PMC2362731